BMC cancer
Predicting PD-L1 expression in advanced EGFR-mutant lung adenocarcinoma patients using NECT, CECT radiomics and clinical features.
Jinjin Li, Ziyi Yang, Liangzhong Liu, Fei Tang, Taihao Zheng, Chao Zhang, Yuan Peng, Zhenzhou Yang, Zhiming Zhou, Benxu Tan, Xiaoyue Zhang
Published: 202610.1186/s12885-025-15514-w
No abstract available for this study.